Robert I Misbin1. Show Affiliations » 1. Division of Endocrine and Metabolic Drug Products, Food and Drug Administration, Rockville, Maryland, USA. misbinr@cder.fda.gov
Abstract
Entities: Disease
Mesh: See more » Diabetes Mellitus/drug therapyDrug Approval/methodsHumansHypoglycemic Agents/therapeutic useRisk AssessmentUnited StatesUnited States Food and Drug Administration/standards
Substances: See more » Hypoglycemic Agents
Year: 2005 PMID: 16186303 DOI: 10.2337/diacare.28.10.2573
Source DB: PubMed Journal: Diabetes Care ISSN: 0149-5992 Impact factor: 19.112